Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jan 13, 2026, 4:00 PM EST
1.115
+0.025 (2.28%)
After-hours: Jan 13, 2026, 7:35 PM EST
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $15.02 million as of January 13, 2026. Its market cap has decreased by -41.31% in one year.
Market Cap
15.02M
Enterprise Value
9.15M
1-Year Change
-41.31%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $15.02M, a decrease of -86.97%. That is a compound annual growth rate of -22.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 15.30M | 13.33% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |